Three years on estrogen and testosterone blockers: what the science says

What did @lillyallers actually say?

After hitting three years on estrogen and testosterone blockers, @lillyallers walked through the physical and psychological changes she's experienced: softer hair and skin, a lighter voice, breast growth that's still progressing, and what she calls her "reproductive system getting shut down on its own." She also disclosed a gap of several months last year where she lost access to her hormones entirely, attributing that to policy-level barriers rather than personal choice. The video is a mix of personal update and political commentary, not a medical how-to. That distinction matters when evaluating what she actually claimed versus what viewers might take away.

She didn't recommend doses, name specific medications, or tell anyone to start or stop anything. That's worth noting upfront. This is a lived-experience account, and it should be read as one.

Does the science back this up?

Mostly, yes. The physical changes she describes are well-documented in the peer-reviewed literature on feminizing hormone therapy. The psychological piece is where it gets more interesting, and more supported than people often expect.

Skin texture changes from estrogen therapy are real and measurable. Estrogen increases dermal thickness and collagen content. A 2019 study by Motosko et al. in the International Journal of Dermatology specifically documented skin softening as a consistent finding in transgender women on estrogen. Voice change in MTF transition is trickier. Estrogen alone does not reliably raise fundamental frequency the way testosterone lowers it in trans men. Her voice change likely reflects a combination of factors including vocal training and individual variation, not estrogen acting directly on the larynx, which was already masculinized before she started.

On mental health, the data is actually fairly strong. A 2020 longitudinal study by van der Miesen et al. in Child and Adolescent Psychiatry and Mental Health found significant reductions in depression and anxiety symptoms following gender-affirming hormone therapy. Her description of moving from a "really low mood state" to feeling more secure tracks with that literature.

What did they get wrong (or right)?

The breast growth claim is accurate and well-supported. Estrogen induces breast development in transgender women through the same ductal and glandular mechanisms as in cisgender women, though the degree varies substantially between individuals. Ongoing tenderness after three years is consistent with documented timelines. Breast development can continue for two to five years after starting estrogen, per the UCSF Transgender Care guidelines.

Where she's imprecise is on the voice. She credits hormones for her "lighter, softer voice," but estrogen does not reliably raise vocal pitch. Research by Dacakis et al. and others consistently shows that voice feminization typically requires deliberate training, not just hormones. This isn't a harmful claim, but it could mislead someone expecting their voice to automatically change once they start estrogen.

The phrase "reproductive system getting shut down" is colloquial but directionally accurate. Anti-androgens combined with estrogen suppress testicular function and sperm production. That's real. The framing is casual, but the underlying physiology checks out.

What should you actually know?

The hormone access gap she describes is not a fringe issue. The Trevor Project's 2022 National Survey on LGBTQ Youth Mental Health found that transgender youth who were denied gender-affirming care reported significantly higher rates of suicidality. Disruptions to established hormone therapy carry real physiological consequences including mood destabilization, hot flashes, and return of some masculinizing characteristics over time, depending on duration of interruption.

If you or someone you know loses access to prescribed hormone therapy, contacting a telehealth provider that operates across state lines is one documented option for maintaining continuity of care. The Endocrine Society's 2017 clinical practice guidelines on gender-dysphoria treatment explicitly address the medical necessity of ongoing hormonal therapy once initiated.

One thing the video doesn't address is monitoring. Long-term estrogen therapy requires periodic labs to check estrogen and testosterone levels, liver function, and other markers. That's not a criticism of her, just a gap worth flagging for anyone watching and thinking this is all you need to know.

Bottom line: is this video trustworthy?

As personal testimony, it's honest and reasonably accurate. She's not claiming to be a doctor. She's describing her own three-year experience with feminizing HRT, and the physical changes she cites are consistent with what the literature documents. The voice claim is the one place where the science doesn't fully back her up, and that's worth knowing if you're setting expectations. The discussion of hormone access disruption is genuine and reflects a real policy problem with documented mental and physical health consequences. This isn't a video to base a medical decision on, but it's not spreading misinformation either.